Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host Disease
Status:
Completed
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Beclomethasone combined with prednisone may be an effective treatment for
graft-versus-host disease caused by stem cell transplantation. It is not yet known if
prednisone is more effective with or without beclomethasone in treating gastrointestinal
graft-versus-host disease.
PURPOSE: Randomized phase III trial to determine the effectiveness of prednisone with or
without beclomethasone in treating patients who have graft-versus-host disease afftecting the
gastrointestinal system.